Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
Deletions of CDKN2C in multiple myeloma: Biological and clinical implications
ArticleAbstract: Purpose: Deletions of chromosome 1 have been described in 7% to 40% of cases of myeloma with inconsiPalabras claves:Autores:Brito J.L., Chen-Kiang S., Chiecchio L., Dagrada G.P., Davies F.E., Dickens N.J., Else M., Gonzalez D., Jenner M.W., Johnson D.C., Morgan G.J., Paola E. Leone, Protheroe R.K.M., Ross F.M., Walker B.A.Fuentes:googlescopusHomozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome
ArticleAbstract: Purpose: Myeloma is a clonal malignancy of plasma cells. Poor-prognosis risk is currently identifiedPalabras claves:Autores:Boyd K.D., Brito J.L., Davies F.E., Dickens N.J., Gonzalez D., Gregory W.M., Jenner M.W., Johnson D.C., Morgan G.J., Paola E. Leone, Ross F.M., Walker B.A., Zeisig A.Fuentes:googlescopus